Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Cox

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Spine|July 11, 2000
Relationship between functional evaluation measures and self-assessment in nonacute low back painM E Cox, S Asselin, S A Gracovetsky, et al.
FEBS Letters|March 8, 1993
5-lipoxygenase-activating protein is an arachidonate binding proteinJ A Mancini, M Abramovitz, M E Cox, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 16, 2011
Quantitation of cell-associated borrelial DNA in the blood of Lyme disease patients with erythema migransD Liveris, I Schwartz, D McKenna, et al.
Prostate Cancer and Prostatic Diseases|August 5, 2015
Oral simvastatin administration delays castration-resistant progression and reduces intratumoral steroidogenesis of LNCaP prostate cancer xenograftsJ A Gordon, A Midha, A Szeitz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2002
Multilaboratory comparison of anaerobe susceptibility results using 3 different agar mediaD E Roe, S M Finegold, D M Citron, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2002
Multilaboratory comparison of growth characteristics for anaerobes, using 5 different agar mediaD E Roe, S M Finegold, D M Citron, et al.
Oncogenesis|August 19, 2014
Lyn tyrosine kinase regulates androgen receptor expression and activity in castrate-resistant prostate cancerA Zardan, K M Nip, D Thaper, et al.
Investigational New Drugs|May 19, 2015
A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195B J Eigl, S North, E Winquist, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Spine|July 11, 2000
Relationship between functional evaluation measures and self-assessment in nonacute low back painM E Cox, S Asselin, S A Gracovetsky, et al.
FEBS Letters|March 8, 1993
5-lipoxygenase-activating protein is an arachidonate binding proteinJ A Mancini, M Abramovitz, M E Cox, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 16, 2011
Quantitation of cell-associated borrelial DNA in the blood of Lyme disease patients with erythema migransD Liveris, I Schwartz, D McKenna, et al.
Prostate Cancer and Prostatic Diseases|August 5, 2015
Oral simvastatin administration delays castration-resistant progression and reduces intratumoral steroidogenesis of LNCaP prostate cancer xenograftsJ A Gordon, A Midha, A Szeitz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2002
Multilaboratory comparison of anaerobe susceptibility results using 3 different agar mediaD E Roe, S M Finegold, D M Citron, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2002
Multilaboratory comparison of growth characteristics for anaerobes, using 5 different agar mediaD E Roe, S M Finegold, D M Citron, et al.
Oncogenesis|August 19, 2014
Lyn tyrosine kinase regulates androgen receptor expression and activity in castrate-resistant prostate cancerA Zardan, K M Nip, D Thaper, et al.
Investigational New Drugs|May 19, 2015
A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195B J Eigl, S North, E Winquist, et al.
Pageof 7